课题基金 / 基金详情

Chemokine receptors on neutrophils: functionality and involvement in chronic lung disease

Chemokine receptors on neutrophils: functionality and involvement in chronic lung disease
中性粒细胞上的趋化因子受体:功能及其与慢性肺病的关系
批准号:
115015241
负责人:
Professor Dr. Dominik Hartl
金额:
$0.0万
依托单位国家:
德国
项目类别:
Independent Junior Research Groups
财政年份:
2009
资助国家:
德国
项目状态:
已结题
起止时间:
2008-12-31 至 2015-12-31

项目摘要

项目成果

Professor Dr. Dominik Hartl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic lung diseases such as cystic fibrosis (CF) or chronic obstructive pulmonary disease (COPD) are characterized by an accumulation of neutrophils. Chemokines recruit and activate neutrophils via chemokine receptors (CR). As G-protein-coupled receptors (GPCRs), CR are highly relevant for therapeutic approaches. Therefore, a detailed knowledge on the involvement of specific CR in chronic lung diseases is required. We previously identified the CR CXCR1 on neutrophils as a critical target in chronic lung disease, since we found that CXCR1 mediates key antibacterial neutrophil functions, but is cleaved proteolytically in protease-dominated airway microenvironments. Proteolytic cleavage disabled bacterial killing and induced the release of glycosylated soluble CXCR1 receptor species. We further found that airway neutrophils in chronic lung diseases change their CR expression profile through translocation of intracellular CR. Based on our previous studies we aim to address the following issues in the proposed research group: (1) To investigate specific cellular pathways in neutrophils engaged through CRs, (2) to identify the molecular mechanisms involved in the cleavage and release of CRs, (3) to characterize the functional role of CRs in murine models of chronic lung disease and (4) to evaluate the therapeutic potential of CR modulation in vivo. These studies will provide important information on the mechanisms involved in the pathogenesis of chronic neutrophilic lung diseases, which could lead to new therapeutic approaches.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1183/09031936.00173514
发表时间: 2015-08-01
期刊: EUROPEAN RESPIRATORY JOURNAL
影响因子: 24.3
作者: [Carevic, Melanie, Singh, Anurag, Hartl, Dominik]
通讯作者: Hartl, Dominik
DOI: 10.4049/jimmunol.1202144
发表时间: 2013-02-01
期刊: JOURNAL OF IMMUNOLOGY
影响因子: 4.4
作者: [Rieber, Nikolaus, Brand, Alina, Hartl, Dominik]
通讯作者: Hartl, Dominik
DOI: 10.1183/09031936.00070014
发表时间: 2014-12-01
期刊: EUROPEAN RESPIRATORY JOURNAL
影响因子: 24.3
作者: [Hector, Andreas, Kroener, Carolin, Hart, Dominik]
通讯作者: Hart, Dominik
DOI: 10.1159/000444125
发表时间: 2016-01-01
期刊: JOURNAL OF INNATE IMMUNITY
影响因子: 5.3
作者: [Carevic, M., Oez, H., Hartl, D.]
通讯作者: Hartl, D.
Der Einfluss der sauren Säuger-Chitinase auf die Chemokinantwort des Asthma bronchiale
国内基金
海外基金
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    胡琴
  • 依托单位:
BMP9/BMP type I receptors 通过激活 PPARα保护心肌梗死的机制研究
  • 批准号:
    LQ22H020003
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    陈灵丽
  • 依托单位:
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
  • 批准号:
    81171510
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    李若瑜
  • 依托单位:
Toll样受体在糖尿病视网膜病变中作用及其可能信号传导机制
  • 批准号:
    81141008
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2011
  • 负责人:
    王康
  • 依托单位: